AbCellera Biologics

ABCLNasdaq Canada Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.042 B

$6.93 +6.13%

Close of 7 Aug 2026

Revenue

$75.1M

#2614 by revenue

Earnings

-$146.4M

Loss-making

Shares outstanding

306,611,466

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#112Aurinia PharmaceuticalsAUPH$2.06B
#113Zenas BioPharmaZBIO$2.05B
#114AbCellera BiologicsABCL$2.04B
#115Ocular TherapeutixOCUL$2.02B
#116Agios PharmaceuticalsAGIO$1.93B

Where these numbers come from

Share counts and financials for AbCellera Biologics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.